The European Commission has granted marketing authorization for Supemtek®, a quadrivalent (four-strain) recombinant influenza vaccine, for the prevention of influenza in adults aged 18 ... Nov 20
CHMP has adopted a positive opinion for Supemtek for active immunization for the prevention of influenza in adults... Sep 23
-Advertisements-